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Abstract Previous classification systems of chronic
osteomyelitis have failed to provide objective and prag-
matic guidelines for selection of the appropriate treatment
strategy. In this study, we assessed the short-term treatment
outcome in adult patients with long-bone chronic
osteomyelitis prospectively where a modified host classi-
fication system was integrated with treatment strategy
selection through a novel management algorithm. Twenty-
six of the 28 enrolled patients were available for follow-up
at a minimum of 12 months. The median patient age of was
36.5 years (range 18–72 years). Fourteen patients (54 %)
were managed palliatively, and 11 patients (42 %) were
managed through the implementation of a curative treat-
ment strategy. One patient required alternative treatment in
the form of an amputation. The overall success rate was
96.2 % (95 % CI 80.4–99.9 %) at a minimum of
12-months follow-up. Remission was achieved in all [11/
11] patients treated curatively (one-sided 95 % CI
73.5–100.0 %). Palliative treatment was successful in
92.9 % [13/14] of cases (95 % CI 66.1–99.9 %). In
patients with lower limb involvement, there was a statis-
tically significant improvement of 28.3 (95 % CI
21.0–35.7; SD 17.0) in the AAOS Lower Limb Outcomes
Instrument score (p value\ 0.001). The integrated
approach proposed in this study appears a useful guideline
to the management of chronic osteomyelitis of long bones
in adult patients in the developing world. Further investi-
gation is required to validate the approach, and additional
development of the algorithm may be required in order to
render it useful in other clinical environments.
Keywords Osteomyelitis  Chronic  Classification 
Outcome  Management
Introduction
Long-bone chronic osteomyelitis is challenging to treat in
adult patients. The typical causative organisms possess
characteristics that render greater resistance to the host’s
immune response and antibiotic therapy. Bacteria may
persist in a biofilm-based colony or be intracellular, con-
cealed within osteoblasts [1, 2]. While chronic
haematogenous osteomyelitis is not associated with skele-
tal instability, it frequently involves a large segment of
bone. In contrast, post-traumatic contiguous osteomyelitis
is complicated often by the presence of instability or a
compromised soft tissue envelope. Lastly, there are sys-
temic risk factors present in the host that compromise the
ability of the immune system to combat infection
effectively.
Several classification systems have been proposed, but
none has been accepted universally [3, 4]. Although the
Cierny and Mader classification has been the most popular,
the stratification of the physiological status of the host
remains problematic [5, 6]. The definition of a C-host,
according to this classification, is subjective in nature and
is dependent on the treating surgeon’s ability to predict the
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patient’s response to a therapeutic intervention [7]. The
differentiation between a type B- and C-host is important
as it identifies patients who should be treated curatively or
palliatively [3]. In addition, the lack of standardization in
host classification has made comparison with results from
different studies challenging [8].
There is no evidence-based guidance on the treatment of
chronic osteomyelitis in adults [3]. There is no single-
treatment regimen or surgical procedure that is appropriate
for all patients [9]. Essentially, the choice is between a
curative, a palliative or an alternative approach. Curative
treatment usually involves surgical debridement with or
without complex reconstructive procedures and short-term
pathogen-directed antimicrobial therapy [10]. Palliative
treatment on the other hand typically involves long-term
chronic suppressive antibiotic therapy (CSAT) and rarely
intralesional or minimally invasive surgical intervention
[11]. An alternative treatment strategy is indicated occa-
sionally and may comprise either of amputation of the limb
or a combination of surgical intervention and chronic
suppressive antibiotic therapy. The main difficulty lies in
choosing the correct treatment strategy for each patient, a
process further complicated by the aforementioned lack of
standardization in host stratification.
The limitations of existing classification systems, as
well as the lack of evidence-based guidelines, prompted us
to develop a classification system and treatment algorithm
that would assist in treatment strategy selection in a
developing country. In this study, we investigate the short-
term outcome of treatment in adult patients with long-bone
chronic osteomyelitis where a modified host classification
system was integrated, via a novel management algorithm,
with treatment strategy selection.
Materials and methods
A prospective study was performed on 28 consecutive
patients with long-bone chronic osteomyelitis treated at a
tertiary-level tumour, sepsis, and reconstruction unit. All
adult patients older than 18 years of age and with a mini-
mum follow-up of 12 months were included in the series.
Patients with infections involving the foot or hand, atypical
organisms (including tuberculosis and fungal infections),
arthroplasty-related periprosthetic infection, or early
(within 90 days) post-operative surgical site infection with
stable implants were excluded from the study. Data were
collected with regard to patient demographics, the cause
and site of infection, the initial and final impairment,
causative organisms, management strategy employed, fol-
low-up period, and outcome of treatment in terms of
remission or suppression of infection. Impairment was
assessed by means of the QuickDASH scoring system for
upper limbs or AAOS Lower Limb Outcomes Instrument
(version 2.0) in the case of lower limb involvement
[12, 13].
For the purposes of this study, chronic osteomyelitis was
defined as an infection involving bone, with a duration of at
least 10 days, where the causative organisms were thought
to have persisted either intracellularly or in interactive
biofilm-based colonies. Periprosthetic infections were
excluded from the study based on the current trend of
classifying and treating arthroplasty-related infections as a
separate entity [14]. Following clinical, radiological, and
biochemical evaluation, patients were classified according
to a modified version of the original Cierny and Mader
classification system (Table 1) [7]. In terms of the physi-
ological status of the host, the Cierny and Mader classifi-
cation system was modified in order to provide a more
pragmatic and objective definition of a C-host. A patient
was classified as a C-host if one major or more than two
minor risk factors were present (Table 2). In order to
remove any ambiguity during classification of the
anatomical nature of the disease, this was performed prior
to, rather than following, the debridement. The impairment
resulting from the disease and the nidus of infection was
added to the classification as these factors were to be
considered during the treatment selection process.
Table 1 Modified version of the original Cierny and Mader classi-
fication system that served to guide treatment strategy selection
Classification Characteristic
Physiological
Type A-host No risk factors
Type B-host Less than three minor risk factors
Type C-host One major and/or three or more minor
risk factors
Pathoanatomy
I—Medullary No cortical sequestration
II—Cortical Direct contiguous involvement in
cortex only
III—Combined (stable) Both cortex and medullary regions
involved
IV—Combined (unstable) As for III plus unstable prior to
debridement
Nidus
Sequestrum Cortical sequestrum present
Implant Biofilm-based infection in the
presence of implant
No identifiable nidus Minimal necrosis osteomyelitis
Impairment
Minimal Patient able to perform ADL
(activities of daily living)
Severe Unable to perform ADL
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The modified classification system was integrated with
treatment strategy selection through the implementation of
a novel management algorithm (Fig. 1). All C-hosts, as
well as A- or B-hosts with minimal impairment, no iden-
tifiable source and no skeletal instability, were managed
palliatively. All remaining A- and B-hosts were treated
curatively. Those C-hosts with severe impairment com-
bined with skeletal instability were managed through the
implementation of an alternative treatment strategy. This
involved either amputation or chronic suppressive antibi-
otic therapy in combination with external fixation with or
without intralesional debridement.
Curative treatment involved marginal or wide resection,
dead space management, provision of bony stability, soft
tissue reconstruction, and/or skeletal reconstruction, in
conjunction with pathogen-directed adjuvant antibiotics for
a period of 6 weeks. In cases without skeletal instability
(Cierny and Mader anatomical type I, II and III lesions),
Table 2 Risk factors used to
stratify the physiological status
of the host
Major risk factors Minor systemic risk factors Minor local risk factors
CD4 count\350 cells/mm
3 HIV infection Poor soft tissues requiring flap
Albumin\30 g/l Anaemia Chronic venous insufficiency
HbA1C C8 % Smoking Peripheral vascular disease
Cellulitis or abscess formation Diabetes mellitus Previous radiation therapy
Malignancy at site of infection Rheumatoid arthritis Surgery will result in instability
Pathological fracture Chronic lung disease Adjacent joint stiff/arthritic
Chronic cardiac failure Heterotopic ossification
Paraplegia/quadriplegia Failed reconstruction elsewhere
Drug or substance abuse Foot involvement
Chronic corticosteroid use Pelvic involvement
Active tuberculosis Adjacent joint involved
Ischaemic heart disease Segmental resection of C6 cm
Cerebrovascular disease Required to achieve cure
Compliance and motivation
Age[ 65
≥ 1 Major risk factor
≥ 3 Minor risk factors
YES (C-host) NO (A/B host)




























Acute infecon following osteosynthesis
(Opmal biomechanical environment)
Fig. 1 Treatment selection algorithm
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the aim was to maintain stability by marginal debridement
through direct unroofing (tangential excision with high-
speed burr) and/or indirect unroofing (medullary reaming).
In cases involving skeletal instability, wide (segmental)
resection was performed and stability provided by circular
external fixation. Dead space management techniques were
tailored to the anatomical nature of the pathology. A
modified version of continuous irrigation, as proposed by
Lautenbach, was used in type I (medullary) post-operative
infections [15, 16]. A solution of 80 mg of gentamicin in
1000 ml 0.9 % NaCl was infused at 125 ml/h through a
single perforated 6-mm drain tube that was placed intra-
medullary through the nail entry site and a distal cortical
window at the site of the previous locking screws. The
irrigation was discontinued, and drain was removed once
the effluent fluid was macroscopically clear. In type III
lesions (stable combined medullary and cortical lesions),
gentamicin-impregnated polymethylmethacrylate (PMMA)
beads (Septopal Merck, Darmstadt Germany) were used
and removed at 6–8 weeks. Emphasis was placed on soft
tissue reconstruction with the closure of soft tissue defects
with well-perfused healthy tissue. Where direct primary
closure was deemed unfeasible, a plastic surgeon per-
formed closure with a tissue flap with preference given to
muscular flaps. Post-operatively, all patients were treated
with generic parenteral antibiotics in the form of cefazolin
and imipenem until the 7-day microscopy, culture, and
sensitivity (MCS) results became available. Oral antibiotic
therapy, in the form of two agents that were tailored to the
culture and sensitivity results, was commenced subse-
quently and continued for a period of 6 weeks.
Following this period, reconstruction of segmental bone
defects in Cierny and Mader type IV lesions was under-
taken if clinical and biochemical evaluation confirmed the
absence of active infection. The treatment protocol dictated
that the size of the bone defect would determine the nature
of the subsequent skeletal reconstruction procedure.
Defects less than 1–2 cm in magnitude were managed by
acute shortening (Fig. 2). In long bones other than the tibia,
defects between 2 and 4 cm in size were managed using the
Masquelet technique, involving autogenous bone grafting
into an induced membrane. Tibial defects larger than 2 cm
and gaps in other long bones in excess of 4 cm were treated
through the use of bone transport.
Palliative treatment involved the use of chronic sup-
pressive antibiotic therapy (CSAT) in the form of
trimethoprim–sulfamethoxazole (800 mg/160 mg twice
daily) and rifampicin (600 mg daily). In cases where the
general condition of the patient and local soft tissues
allowed, an intralesional excision of discreet exposed
sequestra was performed. In this series, all cases treated by
an alternative treatment strategy required amputation of the
limb.
Following a minimum 12-month follow-up period
treatment, success or failure was determined. Success was
defined as achievement of remission through a curative
treatment strategy or attainment of suppression in patients
treated palliatively. Remission was defined as the absence
of clinical signs of infection [8]. Suppression was defined
as subjective resolution of infection symptoms and signs
from the patient’s point of view to the extent that the
patient required no additional treatment. Treatment failure
was defined as the failure to achieve the predetermined
goal (remission or suppression). The outcome was also
reported as failure if unplanned re-operation was required
or if the patient was dissatisfied with the outcome.
Fig. 2 X-ray images of a case involving pre-operative instability
(anatomical type IV infection). a This 72-year-old diabetic patient
presented with a septic non-union of the humerus following multiple
previous surgeries. b Reconstruction of the post-debridement defect
involved acute shortening, bone graft, and circular external fixation.
c Radiological images following removal of external fixator
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Data were analysed using Stata 13.0 (StataCorp. 2013.
Stata Statistical Software: Release 13. College Station, TX:
StataCorp LP). Continuous variables were summarized
using mean and standard deviation values. If the variable
was skewed or outlier values were present, then the median
and interquartile range were used. Categorical variables
were summarized using frequency tables. Ninety-five per
cent confidence intervals were constructed around sample
point estimates. Changes in functional outcome score from
initial assessment to final assessment were compared using
a paired t test. A p value of\0.05 was considered statis-
tically significant for all tests.
Ethical approval was obtained from the relevant ethics
review boards prior to commencement of the study.
Results
Twenty-six of the 28 enrolled patients were available for
follow-up at 12 months. One patient was excluded on the
basis that he was diagnosed with a surgical site infection in
association with stable fixation of a tibial plafond fracture
in the early post-operative period. This infection was
therefore not treated as chronic osteomyelitis. The second
patient excluded was a 77-year-old male with post-opera-
tive chronic osteomyelitis following cephalomedullary
nailing of a subtrochanteric fracture. The patient was lost to
follow-up after the initial visit, and attempts to contact the
patient were unsuccessful. The median age of the remain-
ing patients was 36.5 years (range 18–72 years;
interquartile range 24 years). Seven patients had chronic
haematogenous osteomyelitis, eight had post-operative
infections, nine developed chronic osteomyelitis after open
fractures, and two patients developed contiguous chronic
osteomyelitis as a result of direct local extension. The tibial
diaphysis was the most commonly involved site (Table 3).
Culture results, from tissue samples taken at the time of
debridement in patients who were treated curatively,
revealed a variety of causative organisms (Table 4).
Classification
Three patients (12 %) were classified as A-hosts, 11
patients (42 %) as B-hosts, and 12 (46 %) as C-hosts. Six
patients classified as C-hosts had at least one major risk
factor and six other patients on the basis of three or more
minor risk factors. Of the 12 C-hosts, six had both a major
and more than two minor risk factors present. Seven
patients (27 %) were HIV-positive with a mean CD4 count
of 401 cells/mm3 [range 220–986 cells/mm3; standard
deviation (SD) 238 cells/mm3]. A variety of additional risk
factors were identified amongst the patients enrolled
(Fig. 3). Nine patients (35 %) were smokers, and three
patients (12 %) had hypoalbuminemia. The soft tissues in
ten patients were considered to represent a significant risk
factor for the development of complications following
Table 3 Site of infection
Site of infection Number of patients
Tibia diaphysis 12 (46 %)
Femur diaphysis 8 (30 %)
Tibial plateau 2 (8 %)
Tibial plafond 1 (4 %)
Humerus diaphysis 2 (8 %)
Ulna shaft 1 (4 %)
Table 4 Micro-organism cultured from tissue samples taken during
debridement in patients treated curatively








































































































































































Fig. 3 Risk factors identified in the series of cases
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surgery unless addressed by flap or other means. Cellulitis
and abscess formation, precluding definitive surgery as the
first line of treatment, were present in three patients.
Peripheral vascular disease or chronic venous insufficiency
with lipodermatosclerosis was present in three patients.
The infection involved the adjacent joint in five cases, and
there was significant loss in range of motion of the adjacent
joint in the additional two patients. Other risk factors
included previous radiation, chronic renal failure requiring
dialysis and chronic corticosteroid use in one patient, dia-
betes mellitus in one patient, and age over 65 years in two
patients. In terms of the anatomical extent of the disease,
20 patients had type III infection, five patients had pre-
operative instability, and in one patient, the infection was
confined to the medullary cavity. The mean initial AAOS
Lower Limb Outcomes score in patients with lower limb
involvement was 58.2 (range 21–100; SD 22.9). In three
cases, the upper limb was involved, with a mean initial
QuickDASH score of 18.2 (range 2.3–29.5; Table 5).
Management
Fourteen patients (54 %) were managed palliatively, and 11
patients (42 %) were managed through the implementation
of a curative treatment strategy. One patient required alter-
native treatment in the form of an amputation. This patient
had infection and bone loss following a neglected open
fracture and was classified as a C-host on the basis of the
presence of two major and two minor risk factors. The pal-
liative treatment group comprised of 11 C-hosts and three
B-hostswho had stable lesionswithminimal impairment and
no identifiable sequestra. All patients in the palliative treat-
ment group received chronic suppressive antibiotic ther-
apy—trimethoprim–sulfamethoxazole (800 mg/160 mg
twice daily) and rifampicin (600 mg daily)—for a period of
3–6 months. One patient, who had an exposed sequestrum in
the region of the tibial plateau, required an additional
intralesional excision (simple sequestrectomy).
In the curative treatment group, surgical intervention
involved marginal debridement (direct and/or indirect
unroofing) in ten patients. Wide (segmental) resection of
the ulna diaphysis, without subsequent reconstruction, was
performed in one patient. Dead space management
involved a modified Lautenbach continuous irrigation
system in six cases, PMMA beads in four patients, and
local muscle flap in one case. Primary soft tissue closure
was obtained for all cases in the curative group. Direct
primary closure of the wound was performed in ten cases,
and in one instance, a local muscle flap was required. In the
two patients, in whom skeletal stabilization and recon-
struction were required, acute shortening and Ilizarov cir-
cular external fixation were performed. Union was
achieved in both of these cases. All patients treated cura-
tively received a combination of two oral antibiotics for a
period of 6 weeks.
Outcome
The overall success rate was 96.2 % (95 % CI
80.4–99.9 %) after a minimum of 12 months of follow-up.
Remission was achieved in all [11/11] patients treated
curatively (one-sided 95 % CI 73.5–100.0 %). Palliative
treatment was successful in 92.8 % of cases (95 % CI
66.1–99.9 %), with suppression in 46 % and remission in
the remaining 54 % of these patients. The overall mean
final AAOS Lower Limb Outcomes score was 86.6 (range
51–100; SD 14.5). This equated to a statistically significant
(p value\ 0.001) mean improvement of 28.3 (95 % CI
21.0–35.7, SD 17.0). In the upper limb, the mean final
overall QuickDASH score was 75 (range 72.5–86.4), with a
mean improvement of 54.3 (range 45.5–84.1). There was
comparable improvement in the functional outcome scores
in the palliative and curative treatment groups (Table 5).
One treatment failure occurred in the palliative treat-
ment group in a patient who required regular dialysis as a
result of Goodpasture syndrome. This patient had extensive
involvement in the entire femoral diaphysis after irradia-
tion for a sarcoma, peripheral vascular disease and avas-
cular necrosis of the femoral head. A hip disarticulation
was required when the palliative treatment protocol was
abandoned.
Table 5 Functional outcome
Category n Mean SDc Range p valued
Overall lower extremitya 23
Initial 52 21.2 21–100
Final 89 11.6 51–100
Improvement 27 18.4 0–49 \0.001
Overall upper extremityb 3
Initial 75 7.4 72.5–86.4
Final 18.2 13.6 2.3–29.5
Improvement 54.3 20.2 45.5–84.1 0.03
Palliative groupa 14
Initial 51.1 22.9 28–100
Final 92.5 16.8 51–100
Improvement 25.5 17.1 0–54 \0.001
Curative groupa 8
Initial 61 21.3 34–94
Final 91 9.1 74–100
Improvement 27.5 17.4 6–48 \0.01
a AAOS Lower Limb Outcomes Instrument
b QuickDASH
c Standard deviation
d Paired t test
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Discussion
Chronic osteomyelitis management continues to pose a
major challenge to orthopaedic surgeons [11]. The Mayo
Clinic reported a 20 % failure rate in the management of
chronic infections [17]. Twenty years later, the disease
remains difficult to cure as was acknowledged in a recent
Cochrane review on antibiotic therapy in chronic
osteomyelitis [18]. The combined remission rate, in this
analysis of four randomized controlled trials, was 78.8 %
at 12 months. Specialized units have, however, been able
to achieve superior results. Cierny, for example, achieved
success in 84 % of patients managed curatively at 2-year
follow-up [10]. The Bone Infection Unit in the UK reported
an impressive cure rate of 90 % at 5-year follow-up [9].
While the multidisciplinary nature of the service offered by
these specialized units is bound to improve outcomes,
appropriate surgical candidate selection may also play a
role.
Without a pragmatic and objective definition of a C-host
(who should be palliated), the selection of a curative
(surgical) treatment strategy, according to the Cierny and
Mader classification system, is based on prior clinical
experience [7]. By this approach, the expected outcome of
a curative strategy should offer a distinct advantage over
symptomatic treatment or amputation, in order to justify
the potential morbidity and risks involved in limb salvage
surgery [7, 10]. Selecting candidates for surgery on this
basis requires considerable experience as it is based on a
prediction of the patient’s response to treatment. The
experience gained in specialized units will therefore
improve the success of curative treatment strategies due to,
amongst other factors, improved surgical candidate selec-
tion. The approach followed in our study was developed to
serve as a guideline for treatment of chronic osteomyelitis
in a resource-poor clinical environment where treatment by
specialized units is not always easily accessible.
In a previous retrospective series of 109 cases, we were
able to achieve an overall success rate of 90 % at a mean
18-months follow-up through an approach which integrated
the pragmatic host stratification with treatment strategy
selection [19]. In this study, we aimed for a preliminary
validation of a similar approach prospectively. After a
minimum of 12-month follow-up, we achieved an overall
success rate of 96.2 %, with 100 % remission in the curative
group and 92.8 % suppression (or better) in the palliative
group. These results are comparable to those achieved in our
retrospective series, where curative and palliative treatments
were successful in 93 and 87 %, respectively [19].
Although these results appear promising, caution is
advised against widespread implementation of this
approach. The proposed classification system and treatment
algorithm were designed for use in the developing world. It
is unlikely to be suitable in the developed world without
further improvement or modification. Apart from the high
incidence of HIV infection and hypoalbuminemia in our
series, the pattern of causative organisms identified in our
cases appears to differ somewhat from that seen in the
developed world [20].
Additional problems may arise when the algorithm is
tested on a wider range of patients. In one case in this
series, the treatment algorithm was deemed to be inade-
quate as it prescribed chronic suppressive antibiotic ther-
apy (CSAT) in a C-host (on the basis of the presence of
skeletal stability), where amputation was inevitable. This
algorithm error was, however, on the conservative side; in
many C-hosts without skeletal instability, CSAT may
suppress the disease to the extent that amputation may not
be required. Furthermore, the proposed host stratification
criteria could result in the initiation of palliative care in
patients who may have been able to cope with curative
treatment. This approach may hold some benefit as it
emphasizes the importance of host factor modification
prior to surgical intervention. Many high-risk cases who
may initially be classified as C-hosts will become candi-
dates for curative treatment (B-hosts) following imple-
mentation of the appropriate interventions aimed at risk
factor reduction.
There are further limitations to this study. The hetero-
geneous nature of the disease demands a much larger series
of cases to determine whether the algorithm is appropriate.
The follow-up period in this series is too short to determine
the ultimate success rate, and our results are likely to
deteriorate over time due to relapse. While deterioration
can be expected in both groups, it is bound to be more
pronounced in the palliative group. Long-term follow-up
will be required to shed more light on this subject. The lack
of a control group is a further limitation. Randomizing
high-risk patients to high- or low-risk interventions, in
order to identify which factors are associated failure (am-
putation), presents obvious ethical concerns. Future com-
parative studies will, however, be facilitated by the fact
that we have provided a standardized host stratification
system.
Despite these limitations, preliminary results suggest
that our proposed approach may be useful in certain clin-
ical environments. Our modified classification system may
be more relevant to clinicians inexperienced in the man-
agement of chronic osteomyelitis as it is less dependent on
estimation of the response to treatment or the prediction of
instability following debridement. Another important
potential benefit of this approach is that standardized host
stratification may enable the comparison of results from
future studies. It may become possible to compare the
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outcome of different interventions or strategies if the
physiological host status was classified using the same pre-
defined pragmatic criteria. This may, in turn, allow us to
answer many of the questions that remain regarding the
management of adult chronic osteomyelitis [8].
Conclusion
The integrated approach proposed in this study appears to
hold promise in the management of chronic long-bone
osteomyelitis in adult patients in the developing world.
Further investigation is required to validate the approach,
and additional algorithm development may be required in
order to render it useful in other clinical settings.
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